Masimo Corp
NASDAQ:MASI
Masimo Corp
Income from Continuing Operations
Masimo Corp
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Masimo Corp
NASDAQ:MASI
|
Income from Continuing Operations
$81.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
4%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Masimo Corp's Income from Continuing Operations?
Income from Continuing Operations
81.5m
USD
Based on the financial report for Dec 30, 2023, Masimo Corp's Income from Continuing Operations amounts to 81.5m USD.
What is Masimo Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
4%
Over the last year, the Income from Continuing Operations growth was -43%. The average annual Income from Continuing Operations growth rates for Masimo Corp have been -30% over the past three years , -16% over the past five years , and 4% over the past ten years .